Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation

Benzinga 2024-10-02

Views 13

Eli Lilly's valuation stands at $842 billion, 54x projected earnings. Orforglipron could be the first small-molecule weight-loss pill when it launches in 2026, giving Eli Lilly two-year lead before rivals catch

Share This Video


Download

  
Report form
RELATED VIDEOS